|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||216.69 - 219.78|
|52-week range||179.59 - 222.42|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||22.57|
|Forward dividend & yield||2.88 (1.32%)|
|Ex-dividend date||07 Nov 2023|
|1y target est||N/A|
Investors are increasingly optimistic about Labcorp (LH) due to development in targeted high-growth areas.
Labcorp (LH) finalizes the comprehensive laboratory relationship with Legacy Health.
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2023 Earnings Call Transcript October 26, 2023 Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.38, expectations were $3.37. Operator: Welcome to the Laboratory Corporation of America Holdings Third Quarter 2023 Earnings Conference Call. At this time all participants are in listen only mode. After […]